Inderal Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
Conditions:   Pancreatic Cancer;   Hepatocellular Cancer;   Biliary Tract Cancer;   Cholangiocarcinoma Interventions:   Biological: Durvalumab;   Drug: Gemcitabine;   Drug: Nab paclitaxel;   Biological: Tremelimumab;   Drug: Propranolol;   Drug: Cisplatin Sponsor:   AHS Cancer Control Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 11, 2022 Category: Research Source Type: clinical trials